(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SOLUTECH PHARMACEUTICALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SOLUTECH PHARMACEUTICALS

ST13

US500000088770865

Class

5

Filing

88770865

Registration

6836117

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

10/05/2022

Trademark type

Combined

Nice classes

5

Filing date

01/23/2020

Registration date

09/06/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/06/2022

Last transaction

10/05/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

09/15/2016

First use in commerce

09/15/2016

Drawing code

3

Owner type

16

Owner location

Sherman Oaks, CA

Examiner

REEVES, APRIL

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a light bulb design, the light bulb having a base and a half-circle upper bulb part (without a top). Stylized bubbles, represented as circles of differing sizes and shades, appear in and out of the top portion of bulb part. The bulb part includes a stylized reflection represented by an oval in a lighter shade to the left of the bubbles. The words Solutech Pharmaceuticals appear to the right of the design, with Solutech above the word Pharmaceuticals.

Holders and representatives

Holders

Solutech Pharmaceuticals, LLC

Representatives

Steven Berkowitz ETEHAD LAW, APC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationstopical medicated drug delivery systems comprising gelscreamssolutions for dermatological use; transdermal patches featuring preparations for treating old and new hypertrophic or keloid scars; and medical dressings

Publications

History of USPTO decisions and trademark events.

27 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/04/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/04/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/04/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/06/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

09/06/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/21/2022

PUBO

PUBLISHED FOR OPPOSITION

06/21/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/01/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/14/2022

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

05/09/2022

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

08/13/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

11/12/2020

GNSL

LETTER OF SUSPENSION E-MAILED

11/12/2020

CNSL

SUSPENSION LETTER WRITTEN

11/12/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/20/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/19/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/19/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/03/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/03/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/03/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/20/2020

GNRT

NON-FINAL ACTION E-MAILED

04/20/2020

CNRT

NON-FINAL ACTION WRITTEN

04/20/2020

DOCK

ASSIGNED TO EXAMINER

04/13/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/28/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/27/2020

NWAP

NEW APPLICATION ENTERED

01/27/2020

Continuous trademark protection

Get notified about every new filing that threatens SOLUTECH PHARMACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.